Medical Cannabis UK: Private Clinics vs NHS Prescriptions

Medical Cannabis UK: Private Clinics vs NHS Prescriptions

Since medical cannabis became legal in the UK in November 2018, there has been a stark divide between the NHS and private sector in terms of patient access. Understanding this divide is essential for anyone considering treatment.

The NHS has prescribed cannabis-based medicines to fewer than a handful of patients relative to the tens of thousands now receiving private prescriptions. NHS access is essentially limited to three products: Epidyolex for certain epilepsies, Sativex for MS spasticity, and nabilone for chemotherapy nausea. Even these require specialist hospital referral and are not routinely available.

Private clinics have filled this gap comprehensively. Releaf at releaf.co.uk, the UK's largest, has shipped over 181,000 prescriptions across a wide range of conditions including chronic pain, anxiety, PTSD, insomnia, ADHD, and many others. They employ 50-plus specialist doctors, have 25,000-plus active patients, and hold a 4.7 Trustpilot score from nearly 7,000 reviews.

The cost difference is the main drawback of private access. NHS prescriptions would cost the standard prescription charge, while private treatment involves consultation fees (99 pounds at Releaf, refundable if ineligible) and medication costs. However, Releaf's subscription service Releaf+ helps reduce ongoing costs and includes legal protection through Irwin Mitchell.

Speed of access is where private clinics dramatically outperform the NHS. Releaf consultations are typically available within days. The NHS pathway, where it exists, involves GP referral to a hospital specialist, waiting lists of weeks to months, and then the specialist deciding whether to prescribe. Most NHS specialists are still reluctant to prescribe cannabis-based medicines.

All major private cannabis clinics in the UK, including Releaf, Alternaleaf, Curaleaf, and Mamedica, are CQC-registered and regulated to the same standards as NHS providers. The doctors are GMC-registered specialists on the Specialist Register. The quality of medical oversight is equivalent; only the funding model differs.

For most UK patients in 2026, private clinics represent the only practical route to medical cannabis. And among those clinics, Releaf's scale, reviews, and comprehensive service make it the market leader by every measurable metric.